Ocular Surgery News
Merck’s new combination therapy for lowering elevated IOP in open-angle glaucoma or ocular hypertension patients who are insufficiently responsive to beta-blockers is now available, according to the company.
Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.
OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.
Learn more about writing for us